Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Redirecting Immune, Lipid and Metabolic Drivers of Early Cardiovascular Disease: The RESET Cohort Study

NCT06211868 is registered in ClinicalTrials.gov with National University Hospital, Singapore as lead sponsor.

NCT NCT06211868
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06211868 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Redirecting Immune, Lipid and Metabolic Drivers of Early Cardiovascular Disease: The RESET Cohort Study
Lead sponsor
National University Hospital, Singapore
Phase
Observational
Overall status
Recruiting
Start date
March 1, 2024
Completion date
September 1, 2030
Enrollment
3,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiovascular diseases, metabolic syndrome, non-alcoholic fatty liver disease